Loading
Latest filing published 29 Sept 2026 for Precision Biosciences INC, €14k. Read the official filing
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Filings by Geno J. Germano span 2 companies, the busiest being Precision Biosciences Inc and Entera Bio Ltd. In total, 9 filings cover trades dated from 4 May 2024 to 25 September 2026.
Every open-market trade on record is a purchase: 6 purchases worth €106k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant and 2 option exercises. So far in 2026, the count stands at 3 purchases and no sales.
A typical purchase (the median) is worth €16k. Of 6 purchases, 5 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 29 September 2026, reports an open-market purchase of €14k in Precision Biosciences Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations